BR112019006689A2 - métodos e sistemas para análise de dados de cromatografia - Google Patents

métodos e sistemas para análise de dados de cromatografia

Info

Publication number
BR112019006689A2
BR112019006689A2 BR112019006689A BR112019006689A BR112019006689A2 BR 112019006689 A2 BR112019006689 A2 BR 112019006689A2 BR 112019006689 A BR112019006689 A BR 112019006689A BR 112019006689 A BR112019006689 A BR 112019006689A BR 112019006689 A2 BR112019006689 A2 BR 112019006689A2
Authority
BR
Brazil
Prior art keywords
systems
methods
data analysis
chromatography data
process controls
Prior art date
Application number
BR112019006689A
Other languages
English (en)
Inventor
Schilling Bernhard
Shierly Eric
BAK Hanne
Mattila John
Mao Nathan
Carver Scott
Mcdermott Stefanie
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60269959&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112019006689(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of BR112019006689A2 publication Critical patent/BR112019006689A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8603—Signal analysis with integration or differentiation
    • G01N30/8617—Filtering, e.g. Fourier filtering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8693—Models, e.g. prediction of retention times, method development and validation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/889—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 monitoring the quality of the stationary phase; column performance

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mathematical Physics (AREA)
  • Algebra (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Pure & Applied Mathematics (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

as modalidades da presente revelação são direcionadas a métodos e sistemas para avaliar a integridade de processos, sistemas e colunas de cromatografia. os métodos e sistemas podem compreender um ou mais dentre extrair uma combinação de bloco e sinal para análise, realizar uma análise de transição, realizar um ou mais controles de processo estatístico e/ou implementar controles em processo com base nos controles de processo estatístico.
BR112019006689A 2016-10-25 2017-10-25 métodos e sistemas para análise de dados de cromatografia BR112019006689A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662412563P 2016-10-25 2016-10-25
PCT/US2017/058190 WO2018081203A1 (en) 2016-10-25 2017-10-25 Methods and systems for chromatography data analysis

Publications (1)

Publication Number Publication Date
BR112019006689A2 true BR112019006689A2 (pt) 2019-06-25

Family

ID=60269959

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019006689A BR112019006689A2 (pt) 2016-10-25 2017-10-25 métodos e sistemas para análise de dados de cromatografia

Country Status (18)

Country Link
US (4) US10613063B2 (pt)
EP (2) EP4071469A3 (pt)
JP (3) JP7102401B2 (pt)
KR (2) KR20230119729A (pt)
CN (2) CN109923411B (pt)
AU (2) AU2017350807B2 (pt)
BR (1) BR112019006689A2 (pt)
CA (1) CA3039788A1 (pt)
DK (1) DK3532838T3 (pt)
EA (1) EA201990986A1 (pt)
ES (1) ES2924060T3 (pt)
HU (1) HUE059631T2 (pt)
IL (4) IL295211B1 (pt)
MX (3) MX2019004316A (pt)
PL (1) PL3532838T3 (pt)
SG (1) SG11201902667UA (pt)
WO (1) WO2018081203A1 (pt)
ZA (1) ZA201902257B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3454058A4 (en) * 2016-03-14 2020-02-26 Shimadzu Corporation MASS SPECTROMETRY DATA ANALYSIS DEVICE AND PROGRAM FOR MASS SPECTROMETRY DATA ANALYSIS
KR20230119729A (ko) * 2016-10-25 2023-08-16 리제너론 파아마슈티컬스, 인크. 크로마토그래피 데이터 분석을 위한 방법 및 시스템
WO2018098502A1 (en) * 2016-11-28 2018-05-31 Board Of Regents, The University Of Texas System Systems, methods and devices for width-based analysis of peak traces
EA039041B1 (ru) * 2018-04-20 2021-11-25 Янссен Байотек, Инк. Квалификация хроматографической колонки в способах производства для получения композиций антител к tnf
CN109100441B (zh) * 2018-08-23 2021-05-07 西南科技大学 一种液相色谱曲线去除脉冲干扰的方法
JP6791216B2 (ja) * 2018-08-28 2020-11-25 横河電機株式会社 監視プログラム、監視装置、及び監視システム
CN110988232A (zh) * 2019-11-28 2020-04-10 南通乐尔环保科技有限公司 一种色谱基线降噪方法及其装置
JP7452186B2 (ja) * 2020-03-30 2024-03-19 東ソー株式会社 クロマトグラフの運転状態の推定方法
IL297024A (en) * 2020-04-14 2022-12-01 Regeneron Pharma Ultraviolet monitoring of chromatography performance using orthogonal partial least squares
JP2022091322A (ja) * 2020-12-09 2022-06-21 株式会社島津製作所 液体クロマトグラフのｐＨ管理システムおよびプログラム
CN112730712B (zh) * 2020-12-31 2022-06-07 杭州谱育科技发展有限公司 提高lc-ms数据信噪比的方法
CN113321817A (zh) * 2021-07-06 2021-08-31 青岛科技大学 一种纳米木质素制备过程关键变量的分析方法
WO2023052358A1 (en) * 2021-09-28 2023-04-06 Merck Patent Gmbh Methods for monitoring chromatography resins during continuous chromatography operation
CN115825313B (zh) * 2023-02-22 2023-04-11 华谱科仪(北京)科技有限公司 色谱信息检测方法、装置、电子设备和计算机可读介质

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937188A (en) 1986-04-15 1990-06-26 Northeastern University Enzyme activity amplification method for increasing assay sensitivity
US4801726A (en) 1986-04-15 1989-01-31 Northeastern University Repetitive hit-and-run immunoassay and stable support-analyte conjugates; applied to T-2 toxin
US5190864A (en) 1986-04-15 1993-03-02 Northeastern University Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
JPH07111423B2 (ja) * 1986-10-01 1995-11-29 株式会社日立製作所 クロマトグラフのデ−タ処理方法
JPS6486060A (en) * 1987-09-29 1989-03-30 Shimadzu Corp Analysis data processor
US5412083A (en) 1992-04-16 1995-05-02 Northeastern University Carbohydrate heterobifunctional cross-linking reagent
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
AU4986596A (en) 1995-02-16 1996-09-04 Massachusetts Health Research Institute, Inc. Purified tetanus toxoid and toxin
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
JP3180010B2 (ja) * 1995-10-13 2001-06-25 株式会社日立製作所 クロマトグラフ分析装置
KR19990056559A (ko) * 1997-12-29 1999-07-15 윤종용 노이즈 감소방법 및 그 장치
EP0964057B1 (en) 1998-05-11 2004-12-22 Tosoh Corporation Method for separating nucleic acids by means of liquid chromatography
US7303746B2 (en) 1999-06-08 2007-12-04 Regeneron Pharmaceuticals, Inc. Methods of treating eye disorders with modified chimeric polypeptides
US7306799B2 (en) 1999-06-08 2007-12-11 Regeneron Pharmaceuticals, Inc. Use of VEGF inhibitors for treatment of eye disorders
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
IL155002A0 (en) 2000-10-12 2003-10-31 Genentech Inc Reduced-viscosity concentrated protein formulations
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
US7101982B2 (en) 2001-03-30 2006-09-05 Immunex Corporation Control of ph transitions during chromatography
WO2004020971A2 (en) 2002-08-28 2004-03-11 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
CN1777435B (zh) 2002-09-13 2011-01-12 拜奥根Idec公司 通过模拟移动床层析纯化多肽的方法
US20060257972A1 (en) 2003-03-31 2006-11-16 Takashi Ishihara Purification of human monoclonal antibody and human polyclonal antibody
CA2529945A1 (en) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
ES2342539T3 (es) 2003-10-24 2010-07-08 Amgen, Inc. Proceso para la purificacion de proteinas en una fraccion de flujo-directo de cromatografia de interaccion hidrofobica.
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
US7750129B2 (en) 2004-02-27 2010-07-06 Ge Healthcare Bio-Sciences Ab Process for the purification of antibodies
SE0400501D0 (sv) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
SE0400886D0 (sv) 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
US7795405B2 (en) 2004-08-09 2010-09-14 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
WO2006020622A1 (en) 2004-08-09 2006-02-23 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
AU2005296351B2 (en) 2004-10-21 2010-12-02 Cytiva Bioprocess R&D Ab A method of antibody purification
WO2006088650A2 (en) 2005-02-02 2006-08-24 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a vegf inhibitor
WO2007064281A1 (en) 2005-12-02 2007-06-07 Ge Healthcare Bio-Sciences Ab Hydrophobic interaction chromatography
JP2009531371A (ja) 2006-03-28 2009-09-03 エフ．ホフマン−ラ ロシュ アーゲー 抗ｉｇｆ−１ｒヒト・モノクローナル抗体製剤
CN102887955A (zh) 2006-04-05 2013-01-23 艾博特生物技术有限公司 抗体纯化
LT2944306T (lt) 2006-06-16 2021-02-25 Regeneron Pharmaceuticals, Inc. Vfgf antagonisto kompozicijos, tinkamos įvedimui intravitrealiniu būdu
WO2008028974A1 (en) 2006-09-08 2008-03-13 Novo Nordisk A/S Methods of optimizing chromatographic separation of polypeptides
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
US20080299545A1 (en) 2007-03-06 2008-12-04 Shuyuan Zhang Chromatographic methods for assessing adenovirus purity
US8003364B2 (en) 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia viruses using hydrophobic interaction chromatography
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
CA2712732C (en) * 2008-01-25 2018-11-27 Biogen Idec Ma Inc. Automated system and method for monitoring chromatography column performance, and applications thereof
US7897405B2 (en) 2008-02-11 2011-03-01 Thermo Finnigan Llc Method for identifying the elution time of an analyte
US20090277254A1 (en) * 2008-05-09 2009-11-12 Medlmmune, Llc Methods of improving packed-bed chromatography performance
JP5635509B2 (ja) 2008-08-15 2014-12-03 バイオジェン・アイデック・エムエイ・インコーポレイテッド クロマトグラフィーカラムの性能を評価するための方法
US20100069617A1 (en) 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
JP5808249B2 (ja) 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインａアフィニティークロマトグラフィーを用いる抗体の単離および精製
TW201028433A (en) 2008-10-20 2010-08-01 Abbott Lab Viral inactivation during purification of antibodies
JP2012526121A (ja) 2009-05-04 2012-10-25 アボツト・バイオテクノロジー・リミテツド ヒト抗ｔｎｆアルファ抗体の安定した高蛋白質濃度製剤
SI3444335T1 (sl) 2009-06-16 2021-08-31 Genzyme Corporation Izboljšani postopki čiščenja vektorjev rekombinantnega AAV
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
SI3037104T1 (sl) 2009-10-20 2020-10-30 Abbvie Inc. Izolacija in prečiščevanje protiteles anti-IL-13 z uporabo afinitetne kromatografije beljakovine A
US8246833B2 (en) 2009-12-17 2012-08-21 Ge Healthcare Bio-Sciences Ab Chromatography column and maintenance method
AU2011214361C1 (en) 2010-02-12 2016-01-14 Dpx Holdings B.V. Single unit antibody purification
CN102906851B (zh) * 2010-06-10 2015-09-16 国际商业机器公司 分析质谱的方法及***
WO2012030512A1 (en) 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
NZ609469A (en) 2010-11-11 2015-02-27 Abbvie Biotechnology Ltd Improved high concentration anti-tnfα antibody liquid formulations
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
US9943594B2 (en) 2011-10-11 2018-04-17 Sanofi Biotechnology Methods for the treatment of rheumatoid arthritis
TWI589299B (zh) 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
US20140288278A1 (en) 2011-10-31 2014-09-25 Joseph Nti-Gyabaah Chromatography process for resolving heterogeneous antibody aggregates
KR102048189B1 (ko) 2011-11-14 2019-11-25 리제너론 파아마슈티컬스, 인크. Ｇｄｆ8 및/또는 액티빈 ａ를 특이적으로 길항함으로써 근육량과 근육 강도를 증가시키는 조성물 및 방법
MX2014005885A (es) 2011-11-21 2014-09-04 Genentech Inc Purificacion de anticuerpos anti-c-met.
JP6092892B2 (ja) 2011-12-15 2017-03-08 プレステージ バイオファーマ プライベート リミテッド 抗体の精製方法
US20150051843A1 (en) * 2012-01-16 2015-02-19 Leco Corporation Systems and Methods to Process Data in Chromatographic Systems
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013177115A2 (en) 2012-05-21 2013-11-28 Abbvie Inc. Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
US20140154270A1 (en) 2012-05-21 2014-06-05 Chen Wang Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US8941405B2 (en) 2012-08-03 2015-01-27 International Business Machines Corporation FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage
EP2879691B1 (en) 2012-08-06 2019-03-27 Biogen MA Inc. Methods for inactivating enveloped viruses
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
CA2895198A1 (en) 2012-12-20 2014-06-26 Medimmune, Llc Liquid antibody formulation with improved aggregation properties
CA2902854C (en) 2013-03-08 2024-01-23 Genzyme Corporation Integrated continuous manufacturing of therapeutic protein drug substances
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
AU2013384204B2 (en) 2013-03-14 2017-03-16 Abbvie Inc. Low acidic species compositions and methods for producing and using the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
PL2970378T3 (pl) 2013-03-15 2021-12-06 Biogen Ma Inc. Chromatografia oddziaływań hydrofobowych białek w warunkach bez soli
AR095615A1 (es) 2013-03-15 2015-10-28 Alder Biopharmaceuticals Inc Purificación de anticuerpos y monitoreo de pureza
LT2981822T (lt) 2013-05-06 2020-12-28 Scholar Rock, Inc. Kompozicijos ir būdai, skirti augimo faktoriaus moduliacijai
US10111953B2 (en) 2013-05-30 2018-10-30 Regeneron Pharmaceuticals, Inc. Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
TWI682780B (zh) 2013-05-30 2020-01-21 美商再生元醫藥公司 醫藥組成物用於製造治療與ｐｃｓｋ９功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途
TWI755763B (zh) 2013-06-04 2022-02-21 美商再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
KR101569783B1 (ko) 2013-06-05 2015-11-19 한화케미칼 주식회사 항체의 정제 방법
US9150938B2 (en) 2013-06-12 2015-10-06 Orochem Technologies, Inc. Tagatose production from deproteinized whey and purification by continuous chromatography
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
US20150093800A1 (en) 2013-09-05 2015-04-02 Genentech, Inc. Method for chromatography reuse
EP3044323B1 (en) 2013-09-13 2022-04-06 F. Hoffmann-La Roche AG Methods for detecting and quantifying host cell protein in cell lines
CA2921999C (en) 2013-09-13 2023-03-21 Genentech, Inc. Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20160251441A1 (en) 2013-10-25 2016-09-01 Medimmune, Llc Antibody purification
US10115576B2 (en) 2013-12-12 2018-10-30 Waters Technologies Corporation Method and an apparatus for analyzing a complex sample
JP6260351B2 (ja) * 2014-03-04 2018-01-17 株式会社島津製作所 クロマトグラフ用データ処理装置及びデータ処理方法
JO3701B1 (ar) 2014-05-23 2021-01-31 Regeneron Pharma مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
FR3025515B1 (fr) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
JP2017536391A (ja) 2014-12-02 2017-12-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｉｌ−６ｒアンタゴニストを投与することによってドライアイ疾患を治療するための方法
US10696735B2 (en) 2015-01-21 2020-06-30 Outlook Therapeutics, Inc. Modulation of charge variants in a monoclonal antibody composition
TWI710573B (zh) 2015-01-26 2020-11-21 美商再生元醫藥公司 抗伊波拉病毒醣蛋白之人類抗體
CN104748764B (zh) * 2015-04-01 2017-05-24 清华大学 一种声场可视化***中声像平面的空间角度标定方法
TWI756187B (zh) 2015-10-09 2022-03-01 美商再生元醫藥公司 抗ｌａｇ３抗體及其用途
BR112018012801B1 (pt) 2015-12-22 2024-03-12 Regeneron Pharmaceuticals, Inc Usos de uma combinação de anticorpos anti-pd-1 e anticorpos biespecíficos anti-cd20/anti-cd3 e de uma composição farmacêutica
EP3394102A1 (en) 2015-12-22 2018-10-31 Regeneron Pharmaceuticals, Inc. Bispecific anti-cd20/anti-cd3 antibodies to treat acute lymphoblastic leukemia
EP3184119A1 (en) 2015-12-23 2017-06-28 Themis Bioscience GmbH Chromatography based purification strategies for measles scaffold based viruses
GB201602938D0 (en) 2016-02-19 2016-04-06 Ucb Biopharma Sprl Protein purification
US10353868B2 (en) * 2016-04-11 2019-07-16 RMC Pharmaceutical Solutions, Inc. Methods and systems for event based notifications
BR112018075667B1 (pt) 2016-06-14 2024-02-20 Biogen Ma, Inc Métodos para separar um oligonucleotídeo alvo de uma mistura contendo o oligonucleotídeo alvo e uma impureza relacionada com o produto
WO2018027195A1 (en) 2016-08-05 2018-02-08 Abbvie Biotherapeutics Inc. Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing the same
KR20230119729A (ko) * 2016-10-25 2023-08-16 리제너론 파아마슈티컬스, 인크. 크로마토그래피 데이터 분석을 위한 방법 및 시스템
US10626376B2 (en) 2016-11-14 2020-04-21 St. Jude Children's Research Hospital Method for isolating and purifying adeno-associated virus particles using salt
US11697670B2 (en) 2017-08-22 2023-07-11 Biogen Ma Inc. Methods for purifying antibodies having reduced high molecular weight aggregates
WO2019178489A1 (en) 2018-03-16 2019-09-19 Bristol-Myers Squibb Company Metabolic enzyme activity and disulfide bond reduction during protein production
WO2019178495A1 (en) 2018-03-16 2019-09-19 Biogen Ma Inc. Methods for purifying recombinant adeno-associated viruses
EP3774882A1 (en) 2018-03-29 2021-02-17 Bristol-Myers Squibb Company Methods of purifying monomeric monoclonal antibodies
EP3810650A1 (en) 2018-06-19 2021-04-28 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
TW202005694A (zh) 2018-07-02 2020-02-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
US20220267369A1 (en) 2018-07-25 2022-08-25 Merck Sharp & Dohme Corp. Methods of separating host cell lipases from a production protein in chromatographic processes
KR20210045425A (ko) 2018-08-15 2021-04-26 브리스톨-마이어스 스큅 컴퍼니 하류 크로마토그래피에서의 재산화에 의한 단백질 단편화 제어 전략
WO2020096958A1 (en) 2018-11-05 2020-05-14 Bristol-Myers Squibb Company Method for purifying pegylated protein
WO2020172658A1 (en) 2019-02-24 2020-08-27 Bristol-Myers Squibb Company Methods of isolating a protein
EP3948262A1 (en) 2019-03-29 2022-02-09 Bristol-Myers Squibb Company Methods of measuring hydrophobicity of chromatographic resins
JP2022539148A (ja) 2019-06-28 2022-09-07 武田薬品工業株式会社 アデノ随伴ウイルスの精製方法

Also Published As

Publication number Publication date
AU2017350807B2 (en) 2022-07-07
US20180113101A1 (en) 2018-04-26
IL295211B1 (en) 2024-05-01
MX2023009744A (es) 2023-08-30
IL295211A (en) 2022-10-01
EP4071469A2 (en) 2022-10-12
PL3532838T3 (pl) 2022-10-03
AU2022246438A1 (en) 2022-11-03
MX2019004316A (es) 2019-08-05
JP2024028600A (ja) 2024-03-04
KR20190073396A (ko) 2019-06-26
US20200191756A1 (en) 2020-06-18
JP7102401B2 (ja) 2022-07-19
SG11201902667UA (en) 2019-05-30
MX2023009743A (es) 2023-08-30
US11680930B2 (en) 2023-06-20
DK3532838T3 (da) 2022-07-04
JP2020500299A (ja) 2020-01-09
KR20230119729A (ko) 2023-08-16
US10613063B2 (en) 2020-04-07
JP7427721B2 (ja) 2024-02-05
CN109923411B (zh) 2022-05-31
IL289895A (en) 2022-03-01
KR102564393B1 (ko) 2023-08-08
IL265874B (en) 2022-02-01
EP3532838B1 (en) 2022-06-01
EA201990986A1 (ru) 2019-09-30
CA3039788A1 (en) 2018-05-03
IL289895B (en) 2022-09-01
HUE059631T2 (hu) 2022-12-28
EP4071469A3 (en) 2022-12-14
EP3532838A1 (en) 2019-09-04
WO2018081203A1 (en) 2018-05-03
CN109923411A (zh) 2019-06-21
JP2022125254A (ja) 2022-08-26
ES2924060T3 (es) 2022-10-04
CN114858957A (zh) 2022-08-05
US11333642B2 (en) 2022-05-17
IL265874A (en) 2019-06-30
US20220308025A1 (en) 2022-09-29
ZA201902257B (en) 2020-11-25
US20230273163A1 (en) 2023-08-31
IL312194A (en) 2024-06-01
AU2017350807A1 (en) 2019-04-18

Similar Documents

Publication Publication Date Title
BR112019006689A2 (pt) métodos e sistemas para análise de dados de cromatografia
BR112016014387A2 (pt) Sistemas, métodos e aparelho para composição e/ou recuperação digital
BR112018073956A2 (pt) sinalização avançada de uma região mais interessada em uma imagem
BR112018002040A2 (pt) controle de uma nuvem de dispositivo
MX2017014659A (es) Metodos y sistemas para la deteccion de variantes del numero de copias.
BR112017003023A2 (pt) classificação enviesante de gráfico de conhecimento para dados
BR112016028586A2 (pt) análise de importância de vídeo baseado em regras
BR112017008453A2 (pt) detecção automática de incompatibilidade de esquema
BR112017016159A2 (pt) contextos para unidades de árvore de codificação grandes
BR112016024774A2 (pt) sistema de criação de website implementável em um dispositivo de computação, e método implementável em um dispositivo de computação
WO2015195676A3 (en) Computer-implemented tools and methods for extracting information about the structure of a large computer software system, exploring its structure, discovering problems in its design, and enabling refactoring
BR112018006084A2 (pt) dados de tempo/ambiente hiperlocalizados
BR112014017787A8 (pt) Plataforma e interface de múltiplas atividades
BR112016013158A2 (pt) Identificação de candidatos para testes clínicos
BR112016001934A2 (pt) Método para exploração e produção de petróleo e gás, dispositivo de armazenamento legível por máquina não transitório, e, sistema para exploração e produção de petróleo e gás
BR102016015261A8 (pt) ?controlador?
WO2016025623A3 (en) Image linking and sharing
BR112015025384A2 (pt) método
BR112016024471A2 (pt) sistema e método para criptografia em modo de predição de bloco para compressão de fluxo de visor (dsc)
WO2014207644A3 (en) Method and system for grading a computer program
EA201600553A1 (ru) Распределенный анализ анатомического изображения
BR112018073889A8 (pt) Aparelho e método para determinar informações de similaridade
BR112015020423A2 (pt) aparelho para detectar diferentes indivíduos com base em sinais vitais, método para detectar diferentes indivíduos com base em sinais vitais, e, programa de computador
BR112016024015A2 (pt) método, dispositivo de armazenamento legível por computador e sistema
IL261819B (en) SYSTEM, METHOD, AND COMPUTER SOFTWARE PRODUCT FOR DATA PROCESSING

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]